Resorbable Adhesion Barrier Draft Guidance Calls For Randomized Trials
This article was originally published in The Gray Sheet
Executive Summary
Randomized trials are recommended to minimize introduction of bias into studies of resorbable adhesion barriers for use in abdominal and/or pelvic surgery, FDA says in a recently released draft guidance on the devices.